NCT06156085View on ClinicalTrials.gov

Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

November 14, 2023

Primary Completion Date

November 20, 2024

Study Completion Date

December 3, 2024

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan and Amoxicillin

vonoprazan 20 mg and amoxicillin 1000 mg b.i.d. PC for 14days

DRUG

Lansoprazole, Amoxicillin, Clarithromycin and Metronidazole

lansoprazole 30 mg + amoxicillin 1000 mg b.i.d. AC for 7 days, followed by the same PPI + clarithromycin 500 mg + metronidazole 500 mg b.i.d. AC for 7 days

Trial Locations (1)

24352

Fu Jen Catholic University Hospital, Fu Jen Catholic University, New Taipei City

All Listed Sponsors
lead

Fu Jen Catholic University Hospital

OTHER

NCT06156085 - Fourteen-Day Vonoprazan-Based Dual Therapy With Amoxicillin as First-Line Helicobacter Pylori Treatment in Comparison With Extended Sequential Therapy | Biotech Hunter | Biotech Hunter